Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.
J Hepatol.
1989;9:105 - 113.
Benda L, Dittrich H, Ferenzi P, et al. The effectiveness of silymarin therapy on the survival rate of patients with liver cirrhosis [translated from German].
Wien Klin Wochenschr.
1980;92:678 - 683.
Pares A, Planas R, Torres M, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.
J Hepatol.
1998;28:615 - 621.
Horowitz JH, Rypins EB, Henderson JM, et al. Evidence for impairment of transsulfuration pathway in cirrhosis.
Gatroenterology.
1981;81:668 - 675.
Duce AM, Ortiz P, Cabrero C, et al. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis.
Hepatology.
1988;8:65 - 68.
Mato JM, Camara J, Fernandez de Paz J, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.
J Hepatol.
1999;30:1081 - 1089.
Marchesini G, Bianchi G, Rossi B, et al. Nutritional treatment with branched-chain amino acids in advanced liver cirrhosis.
J Gastroenterol.
2000;35(suppl):7 - 12.
Lesbere FX. Effect of endotelon on the capillary fragility index in a specific group: cirrhotic subjects [in French; English abstract].
Gaz Med Fr.
1983;90:332 - 337.
Liu G-T. Pharmacological actions and clinical use of
Fructus schizandrae.
Chin Med J.
1989;102:740 - 749.
Matsuzaki Y, Tanaka N, Osuga T. Is taurine effective for treatment of painful muscle cramps in liver cirrhosis? [letter].
Am J Gastroenterol.
1993;88:1466 - 1467.
Okita M, Watanabe A, Nagashima H. A vegetable protein-rich diet for the treatment of liver cirrhosis.
Acta Med Okayama.
1985;39:59 - 65.
Lieber CS, Robins SJ, Li J, et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon.
Gastroenterology. 1994;106:152 - 159.
Epstein O, Kato Y, Dick R, et al. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis.
Am J Clin Nutr.
1982;36:426 - 430.
Compston JE, Horton LW, Thompson RP. Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.
Gut.
1979;20:133 - 136.
Watson JP, Jones DE, James OF, et al. Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study.
J Gastroenterol Hepatol.
1999;14:1034 - 1040.
Lucena MI, Andrade RJ, de la Cruz JP, et al. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study.
Int J Clin Pharmacol Ther.
2002;40:2 - 8.
Lang I, et al. Hepatoprotective and immunological effects of antioxidant drugs.
Tokai J Exp Clin Med.
1990;15:123 - 127.
Lang I, et al. Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers.
Ital J Gastroenterol.
1990;22:283 - 287.
Lucena MI, Andrade RJ, de la Cruz JP, et al. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study.
Int J Clin Pharmacol Ther.
2002;40:2 - 8.
Leo MA, Aleynik SI, Aleynik MK, et al. Beta-carotene beadlets potentiate hepatotoxicity of alcohol.
Am J Clin Nutr.
1997;66:1461-1469.
Ni R, Leo MA, Zhao J, Lieber CS. Toxicity of beta-carotene and its exacerbation by acetaldehyde in HepG2 cells. A
Alcohol.
2001;36:281-285.
Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity.
Am J Clin Nutr.
1999;69:1071 - 1085.
Kircheis G, Wettstein M, Dahl S, et al. Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.
Metab Brain Dis. 2002;17:453 - 462.
Mendal JN, Roy BK. Studies with Liv.52 in the treatment of infective hepatitis, chronic active hepatitis and cirrhosis of the liver.
Probe. 1983;22:217.
de Silva HA, Saparamadu PA, Thabrew MI, et al. Liv.52 in alcoholic liver disease: a prospective, controlled trial.
J Ethnopharmacol. 2003;84:47 - 50.
European Scientific Cooperative on Phytotherapy. Valerianae radix. Exeter, UK: ESCOP; 1996 - 1997:2. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 4.
Chan TY, Tang CH, Critchley JA. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian).
Postgrad Med J. 1995;71:227 - 228.
Chan TY. An assessment of the delayed effects associated with valerian overdose [letter].
Int J Clin Pharmacol Ther. 1998;36:569.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.